Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $33.32 USD
Change Today -0.38 / -1.13%
Volume 355.3K
MYGN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 07/29/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - myriad genetics inc (MYGN)

Name (Connections)Board RelationshipsTitleKey Developments
Dennis Langer M.D., J.D. 172 RelationshipsDirector, Chairman of Nominating & Governance Committee and Member of Audit Committee 
S. Phanstiel 60 RelationshipsDirector, Chairman of Audit Committee and Member of Nominating & Governance Committee 
Lawrence Best 38 RelationshipsDirector, Member of Audit Committee and Member of Strategic Committee 

Compensation Committee* - myriad genetics inc (MYGN)

Name (Connections)Board RelationshipsTitle
Heinrich Dreismann Ph.D. 94 RelationshipsDirector, Chairman of Compensation Committee and Member of Strategic Committee
Walter Gilbert Ph.D. 34 RelationshipsFounding Scientist, Vice Chairman and Member of Compensation Committee
John Henderson BSc. M.B, Ch.B, MRCP, M.D., Ph.D. 47 RelationshipsChairman, Chairman of Strategic Committee, Member of Nominating & Governance Committee and Member of Compensation Committee
MYGN Compensation vs. Industry
567.2K
363.4K
Chief Executive Officer
Share price activity for MYRIAD GENETICS INC (MYGN)
52 Week Price Performance
MYGN
Industry Average

Nominating Committee* - myriad genetics inc (MYGN)

Name (Connections)Board RelationshipsTitleKey Developments
John Henderson BSc. M.B, Ch.B, MRCP, M.D., Ph.D. 47 RelationshipsChairman, Chairman of Strategic Committee, Member of Nominating & Governance Committee and Member of Compensation CommitteeMyriad Genetics Inc. Announces Executive Changes
02/3/15
Dennis Langer M.D., J.D. 172 RelationshipsDirector, Chairman of Nominating & Governance Committee and Member of Audit CommitteeMyriad Genetics Inc. Names Johnathan M. Lancaster as Vice President of Medical Affairs for Oncology, Myriad Genetic Laboratories, Effective February 9, 2015
01/22/15
S. Phanstiel 60 RelationshipsDirector, Chairman of Audit Committee and Member of Nominating & Governance CommitteeMyriad Genetics Inc. Announces Executive Changes
12/22/14

Corporate Governance Committee* - myriad genetics inc (MYGN)

Name (Connections)Board RelationshipsTitle
John Henderson BSc. M.B, Ch.B, MRCP, M.D., Ph.D. 47 RelationshipsDirector, Chairman of Compensation Committee and Member of Strategic Committee
Dennis Langer M.D., J.D. 172 RelationshipsFounding Scientist, Vice Chairman and Member of Compensation Committee
S. Phanstiel 60 RelationshipsChairman, Chairman of Strategic Committee, Member of Nominating & Governance Committee and Member of Compensation Committee
MYGN and Competitor
Insiders vs. External
Board
17%
83%
Myriad Genetics Inc.
11%
89%
Advanced Drainage Systems, Inc.
25%
75%
Bio-Reference Laboratories Inc.
43%
57%
RadNet, Inc.
11%
89%
Alliance Healthcare Services, Inc.
14%
86%
Genomic Health Inc.
Insiders
External Board Members
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MYGN:US $33.32 USD -0.38

MYGN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Advanced Drainage Systems Inc $27.27 USD -0.31
Alliance HealthCare Services Inc $14.76 USD -0.79
Bio-Reference Laboratories Inc $44.90 USD -0.85
Genomic Health Inc $26.62 USD -0.27
RadNet Inc $6.75 USD +0.31
View Industry Companies
 

Industry Analysis

MYGN

Industry Average

Valuation MYGN Industry Range
Price/Earnings 26.8x
Price/Sales 3.3x
Price/Book 3.5x
Price/Cash Flow 24.6x
TEV/Sales 3.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MYRIAD GENETICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.